-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Inspire Medical Systems, Lowers Price Target to $62

Benzinga·11/03/2026 14:49:12
Diffusion vocale
Barclays analyst Christopher Pasquale maintains Inspire Medical Systems (NYSE:INSP) with a Underweight and lowers the price target from $65 to $62.